A spin-out of Aurora Cannabis (NYSE: ACB TSX: ACB) in September 2018, Australis identifies and invests in the cannabis industry predominantly in the United States, a highly-regulated, fragmented, rapidly-expanding and evolving industry. Investments may include but are not limited to equity, debt or other securities of both public and private companies, financings in exchange for royalties or other distribution streams, and control stake acquisitions. Australis adheres to stringent investment criteria and focuses on significant near and mid-term high-quality opportunities with strong return potentials while maintaining a steadfast commitment to governance and community.
Australis invests in the highly fragmented, rapidly evolving US cannabis space, with a focus on building companies through early stage, diversified and opportunistic investments
Health
Full interview: Australis Capital merges Fintech and Cannabis with the launch of Cocoon Technology
Director Interviews
Full interview: Australis Capital executive optimistic on SAFE Banking Act, talks through milestones in past year
